Tag: Fetal toxicity

The Food and Drug Administration (FDA) has issued a Black Box Warning for candesartan due to its significant risk to an unborn fetus, prompting many to question: **is candesartan a high risk drug?**. While this serious warning is crucial, the medication's overall risk profile depends on a patient's health status, adherence to guidelines, and concurrent medications.

According to the Food and Drug Administration (FDA), candesartan carries a black box warning due to the risk of fetal toxicity, one of its most serious potential consequences. While generally well-tolerated, understanding **what are the worst side effects of candesartan** is critical for patient safety and prompt intervention.

The U.S. Food and Drug Administration (FDA) places black box warnings on medications to highlight serious or life-threatening risks. Olmesartan, an angiotensin II receptor blocker (ARB) used to treat high blood pressure, carries two black box warnings: one for fetal toxicity and another for a severe gastrointestinal condition called sprue-like enteropathy.